According to Onconova Therapeutics's latest financial reports the company's current earnings (TTM) are -$17.31 M. In 2021 the company made an earning of -$16.17 M an increase over its 2020 earnings that were of -$25.16 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | -$17.31 M | 7.08% |
2021 | -$16.17 M | -35.74% |
2020 | -$25.16 M | 17.03% |
2019 | -$21.5 M | 4.67% |
2018 | -$20.54 M | -14.73% |
2017 | -$24.08 M | 22.53% |
2016 | -$19.66 M | -18.14% |
2015 | -$24.01 M | -62.36% |
2014 | -$63.78 M | 2.66% |
2013 | -$62.13 M | 107.68% |
2012 | -$29.92 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Baxter BAX | -$2.36 B | 13,494.87% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | -$97.91 M | 465.67% | ๐บ๐ธ USA |
![]() CTI BioPharma
CTIC | -$0.12 B | 548.96% | ๐บ๐ธ USA |
![]() Cleveland BioLabs
CBLI | -$2.76 M | -84.10% | ๐บ๐ธ USA |
![]() Array Technologies ARRY | -$3.57 M | -79.39% | ๐บ๐ธ USA |